Delivery Order SPE2DR25D3101-SPE2DR26F5W89
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,946.91 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 6, 2026, for the supply of Lidocaine 5% Patch 30s, valued at $2,089.82 under a firm fixed-price contract type. The order, with an ultimate completion date of January 7, 2026, represents a routine pharmaceutical supply transaction executed through the company's existing indefinite delivery contract with DLA Troop Support Medical. This delivery order was not set aside and was awarded on a competitive...
- The Defense Logistics Agency has awarded a delivery order valued at $6,443.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,142.73 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% patches (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,654.12 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on a full and open basis. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,912.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of January 6, 2026, and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,652.37 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch (30-count units) with an ultimate completion date of January 9, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order is a child contract executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,679.70 for Lidocaine 5% Patch 30S, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,555.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with performance at the company's Conshohocken, Pennsylvania location. This firm fixed-price delivery order, awarded on August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,437.38 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units under a firm fixed-price contract. The award was competitively procured without set-aside provisions and is scheduled for completion by June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5W89Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,188.58 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 12, 2026, and was competitively awarded without a set-aside designation. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order was issued as a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerSourceBergen Drug Corp is the operating subsidiary of parent company Cencora, Inc., which holds the master indefinite delivery contract with the Defense Logistics Agency. The company's federal contracting portfolio demonstrates extensive capability in supplying a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. This specific delivery order for topical pain management medication reflects the company's established role as a critical vendor within the DLA's pharmaceutical supply chain, serving Defense Health Agency and other government healthcare systems with essential medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 1/8/26 |